Alerts will be sent to your verified email
Verify EmailPARNAXLAB
|
Parnax Lab
|
IndoAmerican Advance
|
Bio Medica Labs.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.65 % | 0.31 % | 43.58 % |
|
5yr average Equity Multiplier
|
2.74 | 1.07 | 4.59 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 0.15 | 0.9 |
|
5yr Avg Net Profit Margin
|
4.21 % | -36.65 % | 14.7 % |
|
Price to Book
|
1.79 | n/a | 0.0 |
|
P/E
|
14.39 | n/a | 17.33 |
|
5yr Avg Cash Conversion Cycle
|
30.1 Days | 0.0 | 34.88 Days |
|
Inventory Days
|
45.64 Days | 0.0 | 114.83 Days |
|
Days Receivable
|
61.56 Days | 0.0 | 30.75 Days |
|
Days Payable
|
72.37 Days | 167.71 Days | 279.97 Days |
|
5yr Average Interest Coverage Ratio
|
2.99 | -55.68 | 5.69 |
|
5yr Avg ROCE
|
17.86 % | -12.15 % | 39.6 % |
|
5yr Avg Operating Profit Margin
|
13.13 % | -72.03 % | 29.22 % |
|
5 yr average Debt to Equity
|
1.12 | 0.0 | 2.36 |
|
5yr CAGR Net Profit
|
n/a | n/a | 96.99 % |
|
5yr Average Return on Assets
|
4.42 % | -11.02 % | 13.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.3 % | 0.97 % | n/a |
|
Share Pledged by Promoters
|
9.41 % | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.4 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Parnax Lab
|
IndoAmerican Advance
|
Bio Medica Labs.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|